Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis.
Marchais A, Marques da Costa ME, Job B, Abbas R, Drubay D, Piperno-Neumann S, Fromigué O, Gomez-Brouchet A, Redini F, Droit R, Lervat C, Entz-Werle N, Pacquement H, Devoldere C, Cupissol D, Bodet D, Gandemer V, Berger M, Marec-Berard P, Jimenez M, Vassal G, Geoerger B, Brugières L, Gaspar N. Marchais A, et al. Among authors: gandemer v. Cancer Res. 2022 Mar 15;82(6):974-985. doi: 10.1158/0008-5472.CAN-20-4189. Cancer Res. 2022. PMID: 35078815
Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: the ESCALE study (SFCE).
Rudant J, Menegaux F, Leverger G, Baruchel A, Nelken B, Bertrand Y, Hartmann O, Pacquement H, Vérité C, Robert A, Michel G, Margueritte G, Gandemer V, Hémon D, Clavel J. Rudant J, et al. Among authors: gandemer v. Int J Cancer. 2007 Jul 1;121(1):119-26. doi: 10.1002/ijc.22624. Int J Cancer. 2007. PMID: 17330239 Free article.
Childhood Hodgkin's lymphoma, non-Hodgkin's lymphoma and factors related to the immune system: the Escale Study (SFCE).
Rudant J, Orsi L, Monnereau A, Patte C, Pacquement H, Landman-Parker J, Bergeron C, Robert A, Michel G, Lambilliotte A, Aladjidi N, Gandemer V, Lutz P, Margueritte G, Plantaz D, Méchinaud F, Hémon D, Clavel J. Rudant J, et al. Among authors: gandemer v. Int J Cancer. 2011 Nov 1;129(9):2236-47. doi: 10.1002/ijc.25862. Epub 2011 Apr 1. Int J Cancer. 2011. PMID: 21170962
Thymus and mediastinal node involvement in childhood Langerhans cell histiocytosis: long-term follow-up from the French national cohort.
Ducassou S, Seyrig F, Thomas C, Lambilliotte A, Marec-Berard P, Berger C, Plat G, Brugiere L, Ouache M, Barkaoui M, Armari-Alla C, Lutz P, Leverger G, Rialland X, Mansuy L, Pacquement H, Jeziorski E, Gandemer V, Chalard F, Chateil JF, Tazi A, Emile JF, Donadieu J; Investigators of the French LCH Study Group. Ducassou S, et al. Among authors: gandemer v. Pediatr Blood Cancer. 2013 Nov;60(11):1759-65. doi: 10.1002/pbc.24603. Epub 2013 Jun 29. Pediatr Blood Cancer. 2013. PMID: 23813854 Free PMC article.
Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelines.
Seror E, Donadieu J, Pacquement H, Abbou S, Lambilliotte A, Schell M, Curtillet C, Gandemer V, Pasquet M, Aladjidi N, Lutz P, Schmitt C, Deville A, Minckes O, Vanier JP, Armari-Alla C, Thomas C, Gorde-Grosjean S, Millot F, Blouin P, Garnier N, Coze C, Devoldere C, Reguerre Y, Helfre S, Claude L, Clavel J, Oberlin O, Landman-Parker J, Leblanc T. Seror E, et al. Among authors: gandemer v. Pediatr Hematol Oncol. 2016 Oct-Nov;33(7-8):423-437. doi: 10.1080/08880018.2016.1247393. Pediatr Hematol Oncol. 2016. PMID: 27960645 Clinical Trial.
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.
Fresneau B, Orbach D, Faure-Conter C, Sudour-Bonnange H, Vérité C, Gandemer V, Pasquet M, Fasola S, Rome A, Raimbault S, Martelli H, Frappaz D, Le Teuff G, Patte C. Fresneau B, et al. Among authors: gandemer v. Eur J Cancer. 2018 May;95:11-19. doi: 10.1016/j.ejca.2018.02.029. Epub 2018 Mar 28. Eur J Cancer. 2018. PMID: 29604495
Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.
Héritier S, Barkaoui MA, Miron J, Thomas C, Moshous D, Lambilliotte A, Mazingue F, Kebaili K, Jeziorski E, Plat G, Aladjidi N, Pacquement H, Galambrun C, Brugières L, Leverger G, Mansuy L, Paillard C, Deville A, Pagnier A, Lutun A, Gillibert-Yvert M, Stephan JL, Cohen-Aubart F, Haroche J, Pellier I, Millot F, Gandemer V, Martin-Duverneuil N, Taly V, Hélias-Rodzewicz Z, Emile JF, Hoang-Xuan K, Idbaih A, Donadieu J. Héritier S, et al. Among authors: gandemer v. Br J Haematol. 2018 Nov;183(4):608-617. doi: 10.1111/bjh.15577. Epub 2018 Nov 12. Br J Haematol. 2018. PMID: 30421536 Free article. Clinical Trial.
Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE).
de Tersant M, Généré L, Freyçon C, Villebasse S, Abbas R, Barlier A, Bodet D, Corradini N, Defachelles AS, Entz-Werle N, Fouquet C, Galmiche L, Gandemer V, Lacour B, Mansuy L, Orbach D, Pluchart C, Réguerre Y, Rigaud C, Sarnacki S, Sirvent N, Stephan JL, Thebaud E, Gimenez-Roqueplo AP, Brugières L. de Tersant M, et al. Among authors: gandemer v. J Endocr Soc. 2020 Apr 3;4(5):bvaa039. doi: 10.1210/jendso/bvaa039. eCollection 2020 May 1. J Endocr Soc. 2020. PMID: 32432211 Free PMC article.
New dosing nomogram and population pharmacokinetic model for young and very young children receiving busulfan for hematopoietic stem cell transplantation conditioning.
Poinsignon V, Faivre L, Nguyen L, Neven B, Broutin S, Moshous D, Bourget P, Dufour C, Dalle JH, Galambrun C, Devictor B, Kemmel V, De Berranger E, Gandemer V, Vannier JP, Jubert C, Bondu S, Mir O, Petain A, Vassal G, Paci A. Poinsignon V, et al. Among authors: gandemer v. Pediatr Blood Cancer. 2020 Oct;67(10):e28603. doi: 10.1002/pbc.28603. Epub 2020 Jul 24. Pediatr Blood Cancer. 2020. PMID: 32706505
218 results